Morning Market Movers
Can-Fite BioPharma (NYSE: CANF) rose 24.04% to $9.08 after the company reported top-line results of Phase IIb study with CF101 as a Monotherapy for Rheumatoid Arthritis.
United Therapeutics (NASDAQ: UTHR) moved up 23.90% to $108.83 as the company announced the FDA approval of OrenitramExtended-Release Tablets for the treatment of pulmonary arterial hypertension. JP Morgan upgraded the stock from Underweight to Neutral and raised the target price from $62 to $90.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.